• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

KHA-CARI Guideline: peritonitis treatment and prophylaxis.

作者信息

Walker Amanda, Bannister Kym, George Charles, Mudge David, Yehia Maha, Lonergan Maureen, Chow Josephine

机构信息

Department of Nephrology, Royal Children's Hospital, Melbourne, Victoria, Australia.

出版信息

Nephrology (Carlton). 2014 Feb;19(2):69-71. doi: 10.1111/nep.12152.

DOI:10.1111/nep.12152
PMID:23944845
Abstract
摘要

相似文献

1
KHA-CARI Guideline: peritonitis treatment and prophylaxis.KHA-CARI指南：腹膜炎的治疗与预防
Nephrology (Carlton). 2014 Feb;19(2):69-71. doi: 10.1111/nep.12152.
2
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: the influence of peritoneal dialysis systems and solutions on the incidence of peritonitis and catheter-related infections.《社区获得性感染指南》。腹膜炎治疗与预防的证据：腹膜透析系统及溶液对腹膜炎和导管相关感染发生率的影响
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S41-4. doi: 10.1111/j.1440-1797.2004.00296.x.
3
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylactic antibiotics for insertion of peritoneal dialysis catheter.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管插入术的预防性抗生素应用
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S72-5. doi: 10.1111/j.1440-1797.2004.00303.x.
4
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: peritoneal dialysis-associated peritonitis in children.CARI指南。腹膜炎治疗与预防的证据：儿童腹膜透析相关腹膜炎
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S45-51. doi: 10.1111/j.1440-1797.2004.00297.x.
5
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: type of peritoneal dialysis catheter.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管类型
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S59-64. doi: 10.1111/j.1440-1797.2004.00301.x.
6
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: technique of insertion of peritoneal dialysis catheter.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管插入技术。
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S65-71. doi: 10.1111/j.1440-1797.2004.00302.x.
7
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: indications for recommencement of peritoneal dialysis after treatment for peritonitis.《社区获得性肾衰竭指南》。腹膜炎治疗与预防的证据：腹膜炎治疗后重新开始腹膜透析的指征。
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S52-3. doi: 10.1111/j.1440-1797.2004.00298.x.
8
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: timing of commencement of dialysis after peritoneal dialysis catheter insertion.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管插入术后开始透析的时机。
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S76-7. doi: 10.1111/j.1440-1797.2004.00304.x.
9
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: peritoneal dialysis catheter-related infection: exit site and tunnel.CARI指南。腹膜炎治疗与预防的证据：腹膜透析导管相关感染：出口部位与隧道。
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S82-5. doi: 10.1111/j.1440-1797.2004.00294.x.
10
The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylaxis for exit site/tunnel infections using mupirocin.CARI指南。腹膜炎治疗与预防的证据：使用莫匹罗星预防出口部位/隧道感染。
Nephrology (Carlton). 2004 Oct;9 Suppl 3:S86-90. doi: 10.1111/j.1440-1797.2004.00295.x.

引用本文的文献

1
Association of Peritonitis With Cardiovascular Mortality Over Time in the Peritoneal Dialysis Population: An Australia and New Zealand Dialysis and Transplant Registry Study.腹膜透析人群中腹膜炎与心血管死亡率随时间的关联：一项澳大利亚和新西兰透析与移植登记研究
Kidney Int Rep. 2022 Aug 24;7(11):2388-2396. doi: 10.1016/j.ekir.2022.08.008. eCollection 2022 Nov.
2
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.用于预防腹膜透析患者腹膜炎的抗菌药物。
Cochrane Database Syst Rev. 2017 Apr 8;4(4):CD004679. doi: 10.1002/14651858.CD004679.pub3.
3
Changes in the worldwide epidemiology of peritoneal dialysis.
腹膜透析的全球流行病学变化。
Nat Rev Nephrol. 2017 Feb;13(2):90-103. doi: 10.1038/nrneph.2016.181. Epub 2016 Dec 28.
4
The Current State of Peritoneal Dialysis.腹膜透析的现状
J Am Soc Nephrol. 2016 Nov;27(11):3238-3252. doi: 10.1681/ASN.2016010112. Epub 2016 Jun 23.
5
Center-Specific Factors Associated with Peritonitis Risk-A Multi-Center Registry Analysis.与腹膜炎风险相关的特定中心因素——一项多中心注册研究分析
Perit Dial Int. 2016;36(5):509-18. doi: 10.3747/pdi.2015.00146. Epub 2016 Jan 13.
6
Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis.辅助性组织型纤溶酶原激活剂（tPA）和脱氧核糖核酸酶（DNase）用于腹膜透析相关性腹膜炎的临床前评估。
PLoS One. 2015 Mar 5;10(3):e0119238. doi: 10.1371/journal.pone.0119238. eCollection 2015.